Scientists at a British laboratory have developed two pills which can halt the spread of skin cancer by shrinking deadly tumours by half.
Scientists at the GlaxoSmithKline drugs firm say the pills - which could be available within three years - will improve the length and quality of life for those with malignant melanoma, the deadliest form of skin cancer, the Daily Mail reported.
Malignant melanoma is the 'most quickly rising' cancer...
COLUMBUS, Ohio -- Researchers have long known that humans lack a key enzyme -- one possessed by most of the animal kingdom and even plants -- that reverses severe sun damage.
For the first time, researchers have witnessed how this enzyme works at the atomic level to repair sun-damaged DNA.
The discovery holds promise for future sunburn remedies and skin cancer prevention.
Oral cancer kills 21 people a day because it is usually diagnosed too late. Coast Dental is the first and only group to use multispectral imaging to identify and detect oral cancer at its earliest and most curable stages. Advanced screening exams with Identafi® 3000 ultra are now available at all 119 Coast Dental practices in Florida and Georgia.
Tampa, FL (Vocus) July 21, 2010
Coast Dental is now armed with the first and only multispectral imaging device for detecting...
The Maryland Skin Cancer Prevention Program (MSCPP) today announced its endorsement of the SunAWARE program as providing comprehensive and up-to-date advice on sun protection and skin cancer prevention. The MSCPP said it will incorporate SunAWARE’s five simple steps for the prevention and detection of skin cancer into its popular “SunGuard Man™” program for children, and will collaborate with SunAWARE on other educational and research projects.
...
July 20, 2010 08:30 AM Eastern Daylight Time
Archer Biosciences Announces Initiation of Dosing in 3rd Cohort in Metastatic Melanoma Clinical Trial
NEW YORK--(BUSINESS WIRE)--Archer Biosciences, Inc. announced that the trial of its novel, proprietary drug TPI-287 (an abeotaxane) for the treatment of metastatic melanoma has initiated a third drug-escalation cohort. The primary objective of this study is to determine the safety, tolerability and maximum tolerated dose (MTD)...
